{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Exton",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97808",
      "recalling_firm": "ProRx LLC",
      "address_1": "619 Jeffers Cir",
      "address_2": "N/A",
      "postal_code": "19341-2540",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "TX and UT",
      "recall_number": "D-0119-2026",
      "product_description": "Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341.  NDC:  84139-225-02",
      "product_quantity": "2,805 vials",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20251015",
      "center_classification_date": "20251027",
      "report_date": "20251105",
      "code_info": "Lot PRORX052125-4"
    }
  ]
}